VIRGIL THOMPSON - 05 Aug 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Virgil Thompson by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
05 Aug 2022
Net transactions value
$0
Form type
4
Filing time
09 Aug 2022, 16:20:55 UTC
Previous filing
04 Apr 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +1,169 +7.5% 16,693 05 Aug 2022 Direct F1
holding PCSA Common Stock 82,005 05 Aug 2022 By Thompson Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.